-
Does Fasting Alter RRMS Patients’ Immune System and Gut Microbiome?
A 12-week clinical study at Washington University in St. Louis, Missouri, is recruiting 60 people with relapsing-remitting multiple sclerosis to evaluate if intermittent fasting can improve their immune response, metabolism, and gut microbiome — the bacterial community that inhabits the gastrointestinal tract.
Click here to read more: Missouri Trial to Examine if Fasting Alters Gut Microbiome and Immune System of RRMS Patients in Helpful Ways
What do you think about intermittent fasting? Would you participate in a clinical trial on fasting?
Sorry, there were no replies found.
Log in to reply.